EPOCH trial represents the first positive phase 3 study for selective internal radiation therapy.

Atul Verma, MD, Head of the Heart Rhythm program at Southlake Regional Health Centre and Primary Investigator in the SPACE-AF study commented: “We are thrilled to launch the first study of focal ablation through a solid tip catheter with PEF to treat both the pulmonary veins and atrial targets beyond the pulmonary veins including the left atrial posterior wall.

Published research supported by the CDC highlights environmental and cost-savings benefits of replacing mercury sphygmomanometers with electronic blood pressure monitors.

Japan’s first major leap toward digital therapeutics in the field of hypertension .

Miach Orthopedics initiated BEAR III to continue to build upon the extensive base of evidence for the BEAR Implant, which recently received De Novo approval from the U.S. Food and Drug Administration.